These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 31425167

  • 41. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ, Ko J, Damiani G, Funchain P, Knackstedt T, Vij A, Vidimos A, Gastman BR.
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [Abstract] [Full Text] [Related]

  • 42. Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.
    Thomas DC, Han G, Leong SP, Kashani-Sabet M, Vetto J, Pockaj B, White RL, Faries MB, Schneebaum S, Mozzillo N, Charney KJ, Sondak VK, Messina JL, Zager JS, Han D.
    Ann Surg Oncol; 2019 Jul; 26(7):2254-2262. PubMed ID: 31011906
    [Abstract] [Full Text] [Related]

  • 43. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC, Maas CCHM, van der Veldt AAM, Lo SN, Saw RPM, Varey AHR, Scolyer RA, Long GV, Thompson JF, Rutkowski P, Keilholz U, van Akkooi ACJ, Verhoef C, van Klaveren D, Grünhagen DJ.
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [Abstract] [Full Text] [Related]

  • 44. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients.
    Ribero S, Osella Abate S, Pasquali S, Rossi CR, Borgognoni L, Piazzalunga D, Solari N, Schiavon M, Brandani P, Ansaloni L, Ponte E, Silan F, Sommariva A, Bellucci F, Macripò G, Quaglino P, Italian Melanoma Intergroup (IMI).
    Dermatology; 2017 Apr; 233(2-3):205-211. PubMed ID: 28738392
    [Abstract] [Full Text] [Related]

  • 45. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
    Yokota K, Sawada M, Matsumoto T, Hasegawa Y, Kono M, Akiyama M.
    J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
    [Abstract] [Full Text] [Related]

  • 46. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC, McMasters KM, Scoggins CR, Callender GG.
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [Abstract] [Full Text] [Related]

  • 47. [Pathology and prognostic factors of conjunctival melanoma].
    Berta-Antalics AI, Kruse FE, Holbach L.
    Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
    Satzger I, Leiter U, Gräger N, Keim U, Garbe C, Gutzmer R.
    Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
    [Abstract] [Full Text] [Related]

  • 50. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
    Schmitt AR, Brewer JD, Bordeaux JS, Baum CL.
    JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
    [Abstract] [Full Text] [Related]

  • 51. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG, Orfaniotis G, Butterworth M.
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [Abstract] [Full Text] [Related]

  • 52. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL.
    Trans Am Ophthalmol Soc; 2000 Oct; 98():471-92. PubMed ID: 11190037
    [Abstract] [Full Text] [Related]

  • 53. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
    Tuomaala S, Kivelä T.
    Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
    [Abstract] [Full Text] [Related]

  • 54. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC, McMasters KM.
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [Abstract] [Full Text] [Related]

  • 55. Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.
    Han D, Yu D, Zhao X, Marzban SS, Messina JL, Gonzalez RJ, Cruse CW, Sarnaik AA, Puleo C, Sondak VK, Zager JS.
    Ann Surg Oncol; 2012 Oct; 19(11):3335-42. PubMed ID: 22766986
    [Abstract] [Full Text] [Related]

  • 56. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A, Lu Y, Melendez-Elizondo V, Chen M, Gutierrez-Range A, Fadaki N, Thummala S, West-Coffee C, Cleaver J, Kashani-Sabet M, Leong SPL.
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
    Pavri SN, Han G, Khan S, Han D.
    J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.